Bio Property Plant Equipment vs Current Deferred Revenue Analysis
BIO Stock | USD 290.25 1.59 0.54% |
Bio Rad financial indicator trend analysis is way more than just evaluating Bio Rad Laboratories prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bio Rad Laboratories is a good investment. Please check the relationship between Bio Rad Property Plant Equipment and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Property Plant Equipment vs Current Deferred Revenue
Property Plant Equipment vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bio Rad Laboratories Property Plant Equipment account and Current Deferred Revenue. At this time, the significance of the direction appears to have no relationship.
The correlation between Bio Rad's Property Plant Equipment and Current Deferred Revenue is 0.05. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Bio Rad Laboratories, assuming nothing else is changed. The correlation between historical values of Bio Rad's Property Plant Equipment and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Bio Rad Laboratories are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Property Plant Equipment i.e., Bio Rad's Property Plant Equipment and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.05 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Property Plant Equipment
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from Bio Rad's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bio Rad Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Bio Rad's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 25th of May 2024, Enterprise Value is likely to grow to about 1 B, while Selling General Administrative is likely to drop about 481.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.6B | 1.6B | 1.4B | 769.3M | Total Revenue | 2.9B | 2.8B | 2.7B | 1.4B |
Bio Rad fundamental ratios Correlations
Click cells to compare fundamentals
Bio Rad Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bio Rad fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 8.0B | 13.0B | 17.8B | 13.5B | 12.3B | 12.9B | |
Short Long Term Debt Total | 439.8M | 14.1M | 11.0M | 1.2B | 1.4B | 1.5B | |
Other Current Liab | 158.5M | 224.9M | 210.7M | 186.2M | (35.4B) | (33.6B) | |
Total Current Liabilities | 905.5M | 631.5M | 680.9M | 568.7M | 522.8M | 338.4M | |
Total Stockholder Equity | 5.8B | 9.9B | 13.7B | 9.6B | 8.7B | 9.2B | |
Property Plant And Equipment Net | 701.2M | 693.5M | 695.8M | 679.6M | 723.7M | 759.9M | |
Net Debt | (220.9M) | (648.1M) | (459.8M) | 764.0M | 1.0B | 1.1B | |
Retained Earnings | 5.5B | 9.3B | 13.5B | 9.9B | 9.3B | 9.7B | |
Cash | 660.7M | 662.2M | 470.8M | 434.2M | 404.0M | 257.1M | |
Non Current Assets Total | 5.8B | 10.8B | 15.8B | 10.3B | 9.3B | 9.7B | |
Non Currrent Assets Other | (997.7B) | (2.1T) | (3.1T) | (1.8T) | (1.5T) | (1.4T) | |
Cash And Short Term Investments | 1.1B | 996.7M | 875.5M | 1.8B | 1.6B | 1.7B | |
Net Receivables | 392.7M | 419.4M | 423.5M | 494.6M | 500.9M | 272.8M | |
Common Stock Shares Outstanding | 30.2M | 30.2M | 30.2M | 29.8M | 29.2M | 29.1M | |
Liabilities And Stockholders Equity | 8.0B | 13.0B | 17.8B | 13.5B | 12.3B | 12.9B | |
Non Current Liabilities Total | 1.3B | 2.5B | 3.4B | 3.3B | 3.0B | 3.2B | |
Inventory | 554.0M | 622.3M | 572.2M | 719.3M | 780.5M | 819.5M | |
Other Current Assets | 113.3M | 101.5M | 117.8M | 147.8M | 154.0M | 91.6M | |
Other Stockholder Equity | 371.6M | 329.5M | 335.4M | 183.9M | (183.5M) | (174.3M) | |
Total Liab | 2.3B | 3.1B | 4.1B | 3.9B | 3.6B | 3.7B | |
Property Plant And Equipment Gross | 701.2M | 1.5B | 1.5B | 1.5B | 1.8B | 1.9B | |
Total Current Assets | 2.2B | 2.1B | 2.0B | 3.2B | 3.0B | 3.2B | |
Accumulated Other Comprehensive Income | (87.3M) | 282.5M | (175.6M) | (466.8M) | (336.0M) | (319.2M) | |
Short Term Debt | 426.2M | 1.8M | 489K | 465K | 41.4M | 30.8M | |
Accounts Payable | 287.1M | 362.3M | 418.9M | 329.8M | 142.8M | 138.4M | |
Intangible Assets | 145.5M | 199.5M | 253.9M | 332.1M | 320.5M | 188.7M | |
Other Assets | 40.3M | 13K | 82K | 94.6M | 85.1M | 71.4M | |
Long Term Debt | 13.6M | 12.3M | 10.5M | 1.2B | 1.2B | 1.3B | |
Good Will | 264.1M | 291.9M | 347.3M | 406.5M | 413.6M | 339.1M | |
Treasury Stock | (38.4M) | (99.9M) | (106.3M) | (263.6M) | (237.2M) | (225.4M) | |
Property Plant Equipment | 499.3M | 491.4M | 695.8M | 498.6M | 573.4M | 371.9M | |
Current Deferred Revenue | 33.7M | 42.5M | 50.9M | 52.2M | 35.8B | 37.5B | |
Other Liab | 1.2B | 2.4B | 3.4B | 2.0B | 2.3B | 2.4B | |
Short Term Investments | 459.5M | 334.5M | 404.7M | 1.4B | 1.2B | 1.3B | |
Net Tangible Assets | 5.8B | 9.9B | 13.1B | 9.2B | 10.6B | 11.1B | |
Retained Earnings Total Equity | 5.5B | 9.3B | 13.5B | 9.9B | 11.4B | 12.0B | |
Capital Surpluse | 410.0M | 429.4M | 441.7M | 447.5M | 514.6M | 366.5M | |
Deferred Long Term Liab | 997.8M | 2.1B | 3.1B | 1.8B | 2.0B | 2.1B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.797 | Earnings Share (10.68) | Revenue Per Share 90.024 | Quarterly Revenue Growth (0.1) | Return On Assets 0.0169 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.